US Antimony director buys 20,000 shares at $4.635
A United States Antimony Corp director and executive vice president reported buying 20,000 UAMY shares, increasing his direct holdings to 932,881 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UNITED STATES ANTIMONY CORP (UAMY) director and officer Lloyd Bardswich purchased 20,000 shares of common stock on September 1, 2026 in a transaction reported as a purchase in the open market or a private transaction at $4.635 per share. Following this buy, he directly holds 932,881 shares of UAMY common stock. No Rule 10b5-1 trading plan is reported for this transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 20,000 | $4.635 | $93K |
Key Figures
Key Terms
Rule 10b5-1 regulatory
open market financial
beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UAMY report for Lloyd Bardswich?
Was the UAMY insider trade under a Rule 10b5-1 trading plan?
What is Lloyd Bardswich’s role at UNITED STATES ANTIMONY CORP (UAMY)?
AI-generated analysis. How Rhea-AI works. Not financial advice.